Antigen-induced regulatory T cells in autoimmunity (original) (raw)

• Ashton-Rickardt, P. G. et al. Evidence for a differential avidity model of T-cell selection in the thymus. Cell 76, 651–663 (1994).
  CAS PubMed Google Scholar
• Klein, L., Klugmann, M., Nave, K. A., Tuohy, V. K. & Kyewski, B. Shaping of the autoreactive T-cell repertoire by a splice variant of self-protein expressed in thymic epithelial cells. Nature Med. 6, 56–61 (2000).
  CAS PubMed Google Scholar
• Heath, V. L., Moore, N. C., Parnell, S. M. & Mason, D. W. Intrathymic expression of genes involved in organ-specific autoimmune disease. J. Autoimmun. 11, 309–318 (1998).
  CAS PubMed Google Scholar
• Burns, J., Rosenzweig, A., Zweiman, B. & Lisak, R. P. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell. Immunol. 81, 435–440 (1983).
  CAS PubMed Google Scholar
• Arnold, B., Schonrich, G. & Hammerling, G. J. Multiple levels of peripheral tolerance. Immunol. Today 14, 12–14 (1993).
  CAS PubMed Google Scholar
• Saoudi, A., Seddon, B., Heath, V., Fowell, D. & Mason, D. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T-cell subset. Immunol. Rev. 149, 195–216 (1996).
  CAS PubMed Google Scholar
• Zinkernagel, R. M. Localization, dose and time of antigens determine immune reactivity. Semin. Immunol. 12, 163–171 (2000).
  CAS PubMed Google Scholar
• Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I–peptide complexes. J. Exp. Med. 187, 1383–1393 (1998).
  CAS PubMed PubMed Central Google Scholar
• Dooms, H. & Abbas, A. K. Life and death in effector T cells. Nature Immunol. 3, 797–798 (2002).
  CAS Google Scholar
• Lamb, J. R., Skidmore, B. J., Green, N., Chiller, J. M. & Feldman, M. Induction of tolerance in influenza virus-immune T-lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157, 1434–1447 (1983).
  CAS PubMed Google Scholar
• Quill, H. & Schwartz, R. H. Stimulation of normal inducer T-cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J. Immunol. 138, 3704–3709 (1987).
  CAS PubMed Google Scholar
• Sloan-Lancaster, J., Evavold, B. D. & Allen, P. M. Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-presenting cells. Nature 363, 156–159 (1993).
  CAS PubMed Google Scholar
• Powell, J. D., Lerner, C. G. & Schwartz, R. H. Inhibition of cell-cycle progression by rapamycin induces T-cell clonal anergy even in the presence of costimulation. J. Immunol. 162, 2775–2784 (1999).
  CAS PubMed Google Scholar
• Groux, H., Bigler, M., de Vries, J. E. & Roncarolo, M. -G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184, 19–29 (1996).
  CAS PubMed Google Scholar
• Zeller, J. C. et al. Induction of CD4+ T-cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β. J. Immunol. 163, 3684–3691 (1999).
  CAS PubMed Google Scholar
• Lechler, R., Chai, J. -G., Marelli-Berg, F. & Lombardi, G. The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology 103, 262–269 (2001).
  CAS PubMed PubMed Central Google Scholar
• Sayegh, M. H., Khoury, S. J., Hancock, W. W., Weiner, H. L. & Carpenter, C. B. Mechanisms of oral tolerance by MHC peptides. Ann. NY Acad. Sci. 778, 338–345 (1996).
  CAS PubMed Google Scholar
• Miller, A., al-Sabbagh, A., Santos, L. M., Das, M. P. & Weiner, H. L. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151, 7307–7315 (1993).
  CAS PubMed Google Scholar
• McGuirk, P. & Mills, L. Pathogen-specific regulatory T cells provoke a shift in the TH1/TH2 paradigm in immunity to infectious diseases. Trends Immunol. 9, 450–455 (2002).
  Google Scholar
• Suri-Payer, E., Amar, A. Z., Thornton, A. M. & Shevach, E. M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212–1218 (1998).
  CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135–142 (2002).
  CAS Google Scholar
• Sakaguchi, S. et al. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18–32 (2001).
  CAS PubMed Google Scholar
• Gershon, R. K. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903–914 (1971).
  CAS PubMed PubMed Central Google Scholar
• Hall, B. M., Jelbart, M. E., Gurley, K. E. & Dorsch, S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J. Exp. Med. 162, 1683–1694 (1985).
  CAS PubMed Google Scholar
• Hall, B. M., Pearce, N. W., Gurley, K. E. & Dorsch, S. E. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J. Exp. Med. 171, 141–157 (1990).
  CAS PubMed Google Scholar
• Qin, S. X. et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20, 2737–2745 (1990).
  CAS PubMed Google Scholar
• Qin, S. et al. 'Infectious' transplantation tolerance. Science 259, 974–977 (1993).
  CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135–142 (2002).
  CAS Google Scholar
• Kawaguchi-Miyashita, M. et al. Development and cytolytic function of intestinal intraepithelial lymphocytes in antigen-minimized mice. Immunology 89, 268–273 (1996).
  CAS PubMed PubMed Central Google Scholar
• Waldmann, H. Reprogramming the immune system. Immunol. Rev. 185, 227–235 (2002).
  CAS PubMed Google Scholar
• Hong, S. et al. The natural killer T-cell lligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nature Med. 7, 1052–1056 (2001).
  CAS PubMed Google Scholar
• Zhang, X., Izikson, L., Liu, L. & Weiner, H. L. Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J. Immunol. 167, 4245–4253 (2001).
  CAS PubMed Google Scholar
• Thorstenson, K. M. & Khoruts, A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167, 188–195 (2001).
  CAS PubMed Google Scholar
• Harrison, L. C. & Hafler, D. A. Antigen-specific therapy for autoimmune disease. Curr. Opin. Immunol. 12, 704–711 (2000).
  CAS PubMed Google Scholar
• Faria, A. M. & Weiner, H. L. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73, 153–264 (1999).
  CAS PubMed Google Scholar
• Hanninen, A. & Harrison, L. C. γδ T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173, 109–119 (2000).
  CAS PubMed Google Scholar
• Harrison, L. C., Dempsey-Collier, M., Kramer, D. R. & Takahashi, K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184, 2167–2174 (1996).
  CAS PubMed PubMed Central Google Scholar
• Matzinger, P. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
  CAS PubMed Google Scholar
• McHugh, R. S. et al. CD4+CD25+ immunoregulatory T cells: gene-expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311–323 (2002).
  CAS PubMed Google Scholar
• Sundstedt, A., O'Neill, E. J., Nicolson, K. S. & Wraith, D. C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170, 1240–1248 (2003).
  CAS PubMed Google Scholar
• Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911–920 (2002).
  PubMed Google Scholar
• Zelenika, D. et al. Regulatory T cells overexpress a subset of TH2 gene transcripts. J. Immunol. 168, 1069–1079 (2002).
  CAS PubMed Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969–1980 (1998).
  CAS PubMed Google Scholar
• Gavin, M. A., Clarke, S. R., Negrou, E., Gallgos, A. & Reudnsky, A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nature Immunol. 3, 33–41 (2002).
  CAS Google Scholar
• Bach, J. F. Regulatory T cells under scrutiny. Nature Rev. Immunol. 3, 189–198 (2003).
  Google Scholar
• Kassiotis, G., Garcia, S., Simpson, E. & Stockinger, B. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nature Immunol. 3, 244–250 (2002). References 45 and 46 highlight the issue that regulation might occur as a function of competition for space in immunodeficient hosts, which should be taken into account when interpreting data from the transfer of T Reg cells into irradiated or SCID mice.
  CAS Google Scholar
• Homann, D. et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11, 463–472 (1999). This article provides evidence that the bystander-suppressor function of antigen-specific T Reg cells depends on IL-4 and STAT6. Such cells are induced by oral administration of insulin B-chain and they locally suppress aggressive lymphocytes in the pancreatic draining lymph nodes, thereby preventing diabetes.
  CAS PubMed Google Scholar
• Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 184, 387–396 (1996).
  CAS PubMed Google Scholar
• Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756–763 (2002).
  CAS Google Scholar
• Olivares-Villagomez, D., Wensky, A. K., Wang, Y. & Lafaille, J. J. Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis. J. Immunol. 164, 5499–5507 (2000).
  CAS PubMed Google Scholar
• Stephens, L. A. & Mason, D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25− subpopulations. J. Immunol. 165, 3105–3110 (2000).
  CAS PubMed Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  CAS PubMed PubMed Central Google Scholar
• Shevach, E. M. CD4+CD25+ suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389–400 (2002).
  CAS Google Scholar
• Baecher-Allan, C., Brown, J. A., Freeman, G. J. & Hafler, D. A. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167, 1245–1253 (2001).
  CAS PubMed Google Scholar
• Lehmann, J. et al. Expression of the integrin αEβ7 identifies unique subsets of CD25+ as well as CD25− regulatory T cells. Proc. Natl Acad. Sci. USA 99, 13031–13036 (2002).
  CAS PubMed PubMed Central Google Scholar
• Aseffa, A. et al. The early IL-4 response to Leishmania major and the resulting TH2-cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J. Immunol. 169, 3232–3241 (2002).
  CAS PubMed Google Scholar
• Trinchieri, G. Regulatory role of T cells producing both interferon-γ and interleukin-10 in persistent infection. J. Exp. Med. 194, F53–F57 (2001).
  CAS PubMed PubMed Central Google Scholar
• Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. & Sacks, D. L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507 (2002).
  CAS PubMed Google Scholar
• Iwashiro, M. et al. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc. Natl Acad. Sci. USA 98, 9226–9230 (2001). This study provides the first evidence of an important role for T Reg cells in controlling the immunopathology of infectious disease.
  CAS PubMed PubMed Central Google Scholar
• Lepault, F. & Gagnerault, M. C. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164, 240–247 (2000).
  CAS PubMed Google Scholar
• Boitard, C., Yasunami, R., Dardenne, M. & Bach, J. F. T-cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169, 1669–1680 (1989).
  CAS PubMed Google Scholar
• Bach, J. F. Immunotherapy of insulin-dependent diabetes mellitus. Curr. Opin. Immunol. 13, 601–605 (2001).
  CAS PubMed Google Scholar
• Martinez, N. R. & Harrison, L. C. Disabling a constitutive CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. (in the press).
• Weiner, H. L. Induction and mechanism of action of transforming growth factor-β-secreting TH3 regulatory cells. Immunol. Rev. 182, 207–214 (2001).
  CAS PubMed Google Scholar
• Dhodapkar, M. V. & Steinman, R. M. Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans. Blood 100, 174–177 (2002).
  CAS PubMed Google Scholar
• Viney, J. L., Mowat, A. M., O'Malley, J. M., Williamson, E. & Fanger, N. A. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160, 5815–5825 (1998).
  CAS PubMed Google Scholar
• Tarbell, K. V. et al. CD4+ T cells from glutamic acid decarboxylase (GAD)65-specific T-cell receptor-transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196, 481–492 (2002).
  CAS PubMed PubMed Central Google Scholar
• Jordan, M. S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301–306 (2001).
  CAS Google Scholar
• Weiner, H. L. The mucosal milieu creates tolerogenic dendritic cells and TR1 and TH3 regulatory cells. Nature Immunol. 2, 671–672 (2001).
  CAS Google Scholar
• Mayrhofer, G. & Schon-Hegrad, M. A. Ia antigens in rat kidney, with special reference to their expression in tubular epithelium. J. Exp. Med. 157, 2097–2109 (1983).
  CAS PubMed Google Scholar
• Mayer, L. & Shlien, R. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166, 1471–1483 (1987).
  CAS PubMed Google Scholar
• Kaiserlian, D., Vidal, K. & Revillard, J. P. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur. J. Immunol. 19, 1513–1516 (1989).
  CAS PubMed Google Scholar
• Massey, E. J. et al. Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T-cell function within the context of experimental autoimmune encephalomyelitis. Vet. Immunol. Immunopathol. 87, 357–372 (2002).
  CAS PubMed Google Scholar
• Anderton, S. M. & Wraith, D. C. Selection and fine-tuning of the autoimmune T-cell repertoire. Nature Rev. Immunol. 2, 487–498 (2002).
  CAS Google Scholar
• Bergerot, I., Fabien, N., Maguer, V. & Thivolet, C. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes. J. Autoimmun. 7, 655–663 (1994).
  CAS PubMed Google Scholar
• Zang, J. A., Davidson, L., Eisenbarth, G. & Weiner, H. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl Acad. Sci. USA 88, 10252–10256 (1991).
  Google Scholar
• Daniel, D. & Wegmann, D. R. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl Acad. Sci. USA 93, 956–960 (1996).
  CAS PubMed PubMed Central Google Scholar
• Martinez, N. R. et al. Disabling a constitutive CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. (in the press).
• Harrison, L. C. et al. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185, 1013–1021 (1997).
  CAS PubMed PubMed Central Google Scholar
• Pozzilli, P., Signore, A., Williams, A. J. & Beales, P. E. NOD mouse colonies around the world — recent facts and figures. Immunol. Today 14, 193–196 (1993).
  CAS PubMed Google Scholar
• Suzuki, T. in Immune-Deficient Animals in Biomedical Research (eds Rygaard, J., Brunner, N., Graem, N. & Spang-Thomsen, M.) 112–116 (Karger, Basel, 1987).
  Google Scholar
• Imaoka, A., Matsumoto, S., Setoyama, H., Okada, Y. & Umesaki, Y. Proliferative recruitment of intestinal intraepithelial lymphocytes after microbial colonization of germ-free mice. Eur. J. Immunol. 26, 945–948 (1996).
  CAS PubMed Google Scholar
• Mengel, J. et al. Anti-γδ T-cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Immunol. Lett. 48, 97–102 (1995).
  CAS PubMed Google Scholar
• Ke, Y., Pearce, K., Lake, J. P., Ziegler, H. K. & Kapp, J. A. γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J. Immunol. 158, 3610–3618 (1997).
  CAS PubMed Google Scholar
• Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T-cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327–339 (1994).
  CAS PubMed Google Scholar
• Pape, K. A., Merica, R., Mondino, A., Khoruts, A. & Jenkins, M. K. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719–4729 (1998).
  CAS PubMed Google Scholar
• Weaver, D. J. Jr, Liu, B. & Tisch, R. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 586–592 (2001).
  CAS PubMed Google Scholar
• Coon, B., An, L. L., Whitton, J. L. & von Herrath, M. G. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104, 189–194 (1999).
  CAS PubMed PubMed Central Google Scholar
• Bot, A. et al. Plasmid vaccination with insulin B-chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 2950–2955 (2001).
  CAS PubMed Google Scholar
• Wolfe, T. et al. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety. Eur. J. Immunol. 32, 113–121 (2002).
  CAS PubMed Google Scholar
• Garren, H. et al. Combination of gene delivery and DNA vaccination to protect from and reverse TH1 autoimmune disease via deviation to the TH2 pathway. Immunity 15, 15–22 (2001). This study validates the concept that vaccination with autoantigen-encoding DNA can induce a shift towards T H 2 cytokines and prevent disease of the central nervous system. Importantly, the addition of cytokines such as IL-4 enhanced the efficacy of this approach.
  CAS PubMed Google Scholar
• Liu, E. et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J. Clin. Invest. 110, 1021–1027 (2002).
  CAS PubMed PubMed Central Google Scholar
• Weiner, H. L. et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259, 1321–1324 (1993).
  CAS PubMed Google Scholar
• Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530–5539 (2001).
  CAS PubMed Google Scholar
• Van Regenmortel, M. H. V. Synthetic peptides help in diagnosing viral infections. ASM News 64, 332 (1998).
  Google Scholar
• Bergerot, I. et al. Insulin B-chain reactive CD4+ regulatory T cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T cells. Diabetes 48, 1720–1729 (1999).
  CAS PubMed Google Scholar
• Grohmann, U. et al. CTLA-4–Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097–1101 (2002).
  CAS Google Scholar
• Munn, D. H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867–1870 (2002). References 97 and 98 show a new mechanism by which antigen-presenting cells can induce tolerance in their local microenvironment by depleting tryptophane. CTLA4 and IFN-γ can induce the expression of IDO, which catabolizes tryptophane and mediates tolerance.
  CAS PubMed Google Scholar
• Steinman, R. M. & Nussenzweig, M. C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T-cell tolerance. Proc. Natl Acad. Sci. USA 99, 351–358 (2002).
  CAS PubMed PubMed Central Google Scholar
• Belz, G. T. et al. The CD8α+ dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099–1104 (2002).
  CAS PubMed PubMed Central Google Scholar
• Guillot, C. et al. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig. Blood 19 December 2002 (DOI: 10.1182/blood-2002-07-2076).
• Homann, D. et al. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16, 403–415 (2002).
  CAS PubMed Google Scholar
• Tompkins, S. M., Fuller, K. G. & Miller, S. D. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann. NY Acad. Sci. 958, 26–38 (2002).
  CAS PubMed Google Scholar
• von Herrath, M., Coon, B. & Wolfe, T. Tolerance induction with agonist peptides recognized by autoaggressive lymphocytes is transient: therapeutic potential for type 1 diabetes is limited and depends on time-point of administration, choice of epitope and adjuvant. J. Autoimmun. 16, 193–199 (2001).
  CAS PubMed Google Scholar
• Trentham, D. E. et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261, 1727–1730 (1993).
  CAS PubMed Google Scholar
• Thurau, S. R., Diedrichs-Mohring, M., Fricke, H., Arbogast, S. & Wildner, G. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis patients with an MHC–peptide crossreactive with autoantigen — first results. Immunol. Lett. 57, 193–201 (1997).
  CAS PubMed Google Scholar
• Lee, S., Scherberg, N. & DeGroot, L. J. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 8, 229–234 (1998).
  CAS PubMed Google Scholar
• Pozzilli, P. et al. No effect of oral insulin on residual β-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43, 1000–1004 (2000).
  CAS PubMed Google Scholar
• Chaillous, L. et al. Oral insulin administration and residual β-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabete Insuline Orale group. Lancet 356, 545–549 (2000).
  CAS PubMed Google Scholar
• Fukaura, H. et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting TH3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98, 70–77 (1996).
  CAS PubMed PubMed Central Google Scholar
• Hanninen, A., Braakhuis, A., Heath, W. R. & Harrison, L. C. Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes 50, 771–775 (2001).
  CAS PubMed Google Scholar
• Hanninen, A., Martinez, N. R., Davey, G. M., Heath, W. R. & Harrison, L. C. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109, 261–267 (2002). Mucosal administration of antigen is a 'double-edged sword' because of the potential to induce autoaggressive T cells as well as tolerance. This study shows that co-induction of autoaggressive T cells can be prevented by transient co-stimulation blockade. It has important implications for enhancing the efficacy and safety of antigen-specific tolerance in clinical trials.
  CAS PubMed PubMed Central Google Scholar
• Metzler, B. & Wraith, D. C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159–1165 (1993).
  CAS PubMed Google Scholar
• Homann, D., Dyrberh, T., Petersen, J., Oldstone, M. B. & von Herrath, M. G. Insulin in oral immune 'tolerance': a one-amino acid change in the B chain makes the difference. J. Immunol. 163, 1833–1888 (1999).
  CAS PubMed Google Scholar
• Waldo, F. B., van den Wall Bake, A. W., Mestecky, J. & Husby, S. Suppression of the immune response by nasal immunization. Clin. Immunol. Immunopathol. 72, 30–34 (1994).
  CAS PubMed Google Scholar
• Genain, C. P. et al. Late complications of immune deviation therapy in a nonhuman primate. Science 274, 2054–2057 (1996).
  CAS PubMed Google Scholar
• Eisenbarth, G. S. & Kotzin, B. L. Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction. J. Clin. Invest. 111, 179–181 (2003).
  CAS PubMed PubMed Central Google Scholar
• Reijonen, H. et al. Detection of GAD65-specific T cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51, 1375–1382 (2002).
  CAS PubMed Google Scholar
• Herold, K. C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692–1698 (2002).
  CAS PubMed Google Scholar
• Somasundaram, R. et al. Inhibition of cytolytic T-lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β. Cancer Res. 62, 5267–5272 (2002).
  CAS PubMed Google Scholar
• Kumar, V. & Sercarz, E. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. J. Immunol. 161, 6585–6591 (1998).
  CAS PubMed Google Scholar
• Zhang, Z. Y. & Michael, J. G. Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol. 144, 4163–4165 (1990).
  CAS PubMed Google Scholar
• Gilliet, M. & Liu, Y. -J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695–704 (2002).
  CAS PubMed PubMed Central Google Scholar
• Rissoan, M. C. et al. Reciprocal control of T-helper cell and dendritic-cell differentiation. Science 283, 1183–1186 (1999).
  CAS PubMed Google Scholar